The British Menopause Society (BMS) educates, informs and guides health professionals specialising in menopause care and post reproductive health.
One of the benefits of BMS membership is the publication of full consensus statements in the restricted Members’ Area of the website. These address key disorders and controversial topics relating to menopause and post reproductive health. The full statements reflect new studies together with recent medical and scientific information from articles in professional journals, plus informal consensus.
BMS consensus statements are prepared by specialists from the medical advisory council and regularly updated. They are evidence-based, comprehensively referenced and peer reviewed.
They are published in full in the members journal, Post Reproductive Health. Summary and summary practice points versions are available in this public area of the website by clicking on the titles below. Full consensus statement may be made available to non-members for a limited period.
The full Consensus Statements are available in the Members Area but you can click on the following titles for the summary and summary practice points:
- Bioidentical HRT Updated October 2019 – full Consensus Statement available here to non-Members.
- BMS & WHC’s 2020 recommendations on hormone replacement therapy in menopausal women Updated March 2021
- The diagnosis of the menopause and management of oestrogen deficiency symptoms and arthralgia in women treated for breast cancer Published November 2018
- Non-hormonal-based treatments for menopausal symptoms Updated March 2020
- Premature ovarian insufficiency Updated April 2020
- Prevention and treatment of osteoporosis in women Updated February 2018
- Primary prevention of coronary heart disease in women Updated April 2019
- Benefits and risks of HRT before and after a breast cancer diagnosis Updated November 2020
- Urogenital atrophy Updated June 2018